Strategic Expansion Element’s recent and ongoing facility expansions in the Americas, including Charlotte and Houston, indicate increased demand for regulated testing capacity across aerospace, defense, oil and gas, and related industries. This creates cross-sell opportunities for expanded analytical services, faster turnaround, and added in-situ testing capabilities for clients in those sectors.

Comprehensive Life Cycle The combined offering covers the full product lifecycle from development to market, enabling sales discussions around end-to-end analytical support across pharma, plastics, medical devices, packaging, and specialty chemicals. Emphasize one-stop testing and faster path to regulatory readiness for clients seeking integrated solutions.

Regulatory Credibility FDA registration, DEA licensing, cGMP/GLP compliance, and ISO 9001:2015 certification establish a high-trust profile for quality and compliance. Leverage this to win contracts with heavily regulated manufacturers seeking proven partners for validated testing and documentation.

Technology Enablement Investment in advanced laboratories and instrumentation across microscopy, thermal/mechanical properties, molecular characterization, gas/liquid separations, and elemental analysis, plus digital tools like TrackWise and blockchain-backed test reports. Position as a tech-forward partner capable of handling complex tests and secure data management.

Global Expertise, Local Reach Despite a modest employee base, Element has global platform strength and a broad client footprint (over 300 companies) with multiple high-profile facility expansions. Target mid-market and global manufacturers seeking scalable, globally consistent testing services with regional lab access and rapid capacity growth.